melatonin has been researched along with minocycline in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gestwicki, JE; Reinke, AA; Seh, HY | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bohórquez, A; Bonilla, E; Medina-Leendertz, S; Molero, L; Villalobos, V | 1 |
| Aleksoska, E; Cox, SF; Donnan, GA; Howells, DW; Macleod, MR; O'Collins, VE; Van Raay, L | 1 |
| Kelso, ML; Pauly, JR; Scheff, NN; Scheff, SW | 1 |
| Au, J; Berry-Kravis, E; Hagerman, R; Lauterborn, J | 1 |
| Alcocer, S; Álvarez-Mon, M; Bonilla, E; Mosquera, J; Salazar, J; Valero, N | 1 |
| Daulatzai, MA | 1 |
| Bahbiti, Y; Benmhammed, H; Berkiks, I; El Hasnaoui, A; El Hessni, A; Mesfioui, A; Mouden, S; Nakache, R; Ouichou, A; Touil, T | 1 |
| Jin, X; Jin, Y; Wang, G; Wang, T; Yang, J; Zhao, F | 1 |
3 review(s) available for melatonin and minocycline
| Article | Year |
|---|---|
Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.
Topics: Age Factors; Animals; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Magnesium Sulfate; Melatonin; Minocycline; Neuroprotective Agents; Rats; Severity of Illness Index; Stroke; Treatment Outcome | 2011 |
Fragile X syndrome and targeted treatment trials.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Baclofen; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Clinical Trials as Topic; Dendritic Spines; Donepezil; Dopamine; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Indans; Lithium Compounds; Melatonin; Mice; Mice, Knockout; Minocycline; Nootropic Agents; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, GABA; Receptors, Metabotropic Glutamate; Signal Transduction; Vitamin E | 2012 |
Pharmacotherpy and Alzheimer's Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach.
Topics: Alzheimer Disease; Animals; Benzhydryl Compounds; Cognitive Dysfunction; Humans; Melatonin; Memantine; Minocycline; Modafinil | 2016 |
7 other study(ies) available for melatonin and minocycline
| Article | Year |
|---|---|
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
Topics: Amyloid beta-Peptides; Benzothiazoles; Coloring Agents; Congo Red; Fluorescent Dyes; Indoles; Spectrometry, Fluorescence; Thiazoles | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Paraquat-induced oxidative stress in drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid.
Topics: Animals; Antioxidants; Ascorbic Acid; Drosophila melanogaster; Drug Resistance; Glutathione; Herbicides; Male; Melatonin; Minocycline; Oxidative Stress; Paraquat; Serotonin; Survival Rate; Thioctic Acid | 2006 |
Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Avoidance Learning; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Escape Reaction; In Situ Nick-End Labeling; Isoquinolines; Male; Melatonin; Minocycline; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Time Factors; Tritium | 2011 |
Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis.
Topics: Animals; Antiviral Agents; Ascorbic Acid; Brain; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis Virus, Venezuelan Equine; Encephalomyelitis, Venezuelan Equine; Lipid Peroxidation; Male; Melatonin; Mice; Minocycline; Neuroblastoma; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Survival Rate; Treatment Outcome; Viral Load | 2015 |
Postnatal melatonin treatment protects against affective disorders induced by early-life immune stimulation by reducing the microglia cell activation and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Anxiety; Behavior, Animal; Depression; Lipopolysaccharides; Male; Melatonin; Microglia; Minocycline; Oxidative Stress; Prefrontal Cortex; Rats; Rats, Wistar | 2018 |
Roles of Crosstalk between Astrocytes and Microglia in Triggering Neuroinflammation and Brain Edema Formation in 1,2-Dichloroethane-Intoxicated Mice.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Brain; Brain Edema; Cell Polarity; Citrates; Ethylene Dichlorides; Female; Inflammation; Inflammation Mediators; Melatonin; Mice; Microglia; Minocycline; Nerve Tissue Proteins; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2021 |